Bio-Impact supports innovative digital health solutions — including AI-driven technologies and Software as a Medical Device (SaMD) — through tailored regulatory and market access strategies. We help you navigate emerging frameworks, validate clinically, and scale across GCC healthcare systems.
Digital Health Categories
Specialized regulatory expertise across the digital health landscape.
SaMD
Software as a Medical Device across all classifications
AI-Driven Tech
Machine learning and AI-enabled medical solutions
mHealth Apps
Mobile health applications and patient platforms
Connected Solutions
Integrated digital systems and connected devices
What We Deliver
A full-spectrum approach to digital health regulation and market access.
Classification & Pathway
SaMD classification and regulatory route definition
Software Documentation
Technical documentation aligned with international standards
Clinical Validation
Validation strategy and real-world evidence generation
Cybersecurity & Data
Cybersecurity guidance and data governance frameworks
Market Authorization
Submission management and authority engagement
Pilots & Early Access
Pilot program design and early access pathway support
Performance Monitoring
Post-market monitoring and lifecycle management
Adoption & Reimbursement
Healthcare system integration and reimbursement strategy
From Concept to Healthcare Integration
A structured route designed for the unique needs of digital health products.
Define
Classify the product and identify the regulatory pathway
Validate
Clinical validation and real-world evidence generation
Authorize
Market authorization and pilot program execution
Scale
Healthcare integration, monitoring, and reimbursement
Bringing a Digital Health Product to Market?
Let's map the regulatory and adoption pathway for your SaMD, AI solution, or connected health product.
Book a Consultation